Aminologics Co.,Ltd. (KOSDAQ:074430)

Aminologics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	22,160	18,882	11,999	12,738	8,861	8,580
Short-Term Investments	16,500	16,500	16,500	16,500	16,500	16,500
Trading Asset Securities	-	-	-	-	302.04	302.62
Cash & Short-Term Investments	38,660	35,382	28,499	29,238	25,663	25,383
Cash Growth	14.64%	24.15%	-2.53%	13.93%	1.10%	2.58%
Accounts Receivable	5,198	4,498	8,241	5,384	6,334	4,736
Other Receivables	284.18	151.8	175.94	260.15	155.36	42.08
Receivables	5,482	4,650	8,417	5,644	6,489	4,790
Inventory	5,998	6,083	7,977	8,335	6,373	5,103
Prepaid Expenses	171.19	213.72	189.9	285.58	83.86	1.05
Other Current Assets	420.25	188.02	166.43	66.39	69.7	48.02
Total Current Assets	50,732	46,517	45,249	43,569	38,679	35,325
Property, Plant & Equipment	2,971	3,090	2,630	2,826	2,120	1,585
Long-Term Investments	1,942	3,905	4,988	4,368	5,101	3,837
Other Intangible Assets	3,041	3,046	4,054	4,074	17,598	19,119
Long-Term Accounts Receivable	-0	-	-	-	-	-
Long-Term Deferred Tax Assets	-	-	515.44	520.95	1,522	-
Other Long-Term Assets	231.23	231.23	231.48	224.05	221.75	262.73
Total Assets	58,917	56,789	57,668	55,582	65,243	60,129
Accounts Payable	1,987	2,459	648.71	1,550	3,674	3,578
Accrued Expenses	287.29	288.89	247.74	207.15	159.36	160.78
Short-Term Debt	1,000	1,000	1,000	1,000	1,000	1,000
Current Portion of Leases	283.66	283.66	229.42	239.59	185.74	156.14
Other Current Liabilities	331.06	310.79	541.65	431.99	362.01	1,151
Total Current Liabilities	3,889	4,342	2,668	3,429	5,381	6,047
Long-Term Leases	677.6	734.77	589.53	749.49	468.03	524.02
Long-Term Unearned Revenue	17.99	17.12	-	-	-	-
Other Long-Term Liabilities	-0	-0	-	0	-	-
Total Liabilities	4,584	5,094	3,257	4,178	5,849	6,571
Common Stock	8,783	8,783	8,783	8,783	8,783	8,783
Additional Paid-In Capital	118,400	118,400	118,400	118,400	118,400	118,400
Retained Earnings	-71,667	-73,997	-72,377	-74,814	-67,532	-72,892
Comprehensive Income & Other	-1,183	-1,490	-394.49	-965.24	-257.89	-733.3
Shareholders' Equity	54,333	51,695	54,411	51,404	59,393	53,558
Total Liabilities & Equity	58,917	56,789	57,668	55,582	65,243	60,129
Total Debt	1,961	2,018	1,819	1,989	1,654	1,680
Net Cash (Debt)	36,698	33,364	26,680	27,249	24,010	23,703
Net Cash Growth	16.37%	25.05%	-2.09%	13.49%	1.29%	3.45%
Net Cash Per Share	417.85	379.88	303.78	310.26	273.38	269.88
Filing Date Shares Outstanding	87.83	87.83	87.83	87.83	87.83	87.83
Total Common Shares Outstanding	87.83	87.83	87.83	87.83	87.83	87.83
Working Capital	46,843	42,175	42,581	40,140	33,298	29,278
Book Value Per Share	618.63	588.61	619.53	585.29	676.25	609.81
Tangible Book Value	51,291	48,649	50,357	47,330	41,795	34,439
Tangible Book Value Per Share	584.01	553.92	573.36	538.90	475.88	392.13
Land	281.84	281.84	281.84	281.84	281.84	153.26
Buildings	840.38	840.38	840.38	840.38	840.38	582.42
Machinery	7,583	7,584	7,033	6,864	6,349	6,046

Source: S&P Global Market Intelligence. Standard template. Financial Sources.